The German government decided to make a new law that allows people to use a special plant called cannabis for medical reasons. This means doctors can give it to patients who need it to feel better. Before, it was very hard for people in Germany to get this plant legally. Now, the law changed and more people can have access to it. This makes some businesses that grow or sell cannabis very happy because they can make more money and help more customers. The new law also means that doctors don't have to follow as many rules when they prescribe this plant, and patients don't have to be very sick to get it. Read from source...

- The title is misleading and sensationalized. It implies that the new legalization law in Germany creates broader liberties for pharmacists, but it actually affects patients more than pharmacists directly.
- The article focuses too much on the opinions of a single medical cannabis company founder, Ivan Garev, who has a clear conflict of interest and bias towards the legalization. He is not a representative of the whole industry or the pharmacists' association. His quotes should be used sparingly and with caution, as they are not objective or verifiable sources.
- The article does not provide any data or evidence to support its claims about the market size, growth potential, demand, or patient population. It relies on vague and subjective terms like "a lot", "very fast", "much more simple" without defining them or providing any benchmarks or comparisons.
- The article does not address the possible negative consequences or risks of the legalization, such as increased addiction, abuse, crime, or public health costs. It also does not mention the opposition or criticism from other stakeholders, such as law enforcement, parents, doctors, or insurance companies.
- The article uses emotional language and phrases like "revolutionary", "big surprise", "everyone in the world is looking at Germany right now" to appeal to the readers' feelings and emotions, rather than their logic and reason. It also implies that the legalization was a sudden and unexpected event, rather than a result of years of debate and lobbying by various groups.
- The article does not provide any historical or contextual background or explanation for the legalization process, the reasons behind it, the challenges faced by it, or the implications of it. It assumes that the readers are already familiar with the topic and the situation in Germany, which may not be the case for many readers who are interested in learning more about the issue.
- The article does not provide any balance or diversity in its sources, perspectives, or arguments. It only presents one side of the story, that of the medical cannabis industry and its supporters, without acknowledging or challenging any alternative viewpoints or counterarguments. This creates a biased and unbalanced presentation of the issue, which may not reflect the reality or the complexity of the situation.
- The article does not provide any clear or specific objectives, goals, or purposes for its writing. It is unclear what the author wants to achieve or convey with this piece, whether it is to inform, persuade, entertain, or inspire the readers. It also does not indicate who the intended audience or readership of this article is, and how they might react or respond to it.
- The article does

Neutral

Key points:
- The article reports on the legalization of recreational cannabis in Germany for club members only.
- Pharmacists and medical cannabis companies welcome the legalization as a surprise and a revolutionary change from the previous restrictive laws.
- The new law also allows doctors to prescribe cannabis without it being a narcotic, simplifies the relationship between doctors and insurance companies, and expands the patient base beyond chronic diseases.
- The market is expected to grow rapidly in the next few years as more people become eligible for medical cannabis.